Pencil Biosciences Limited is a biotechnology startup based in the United Kingdom, founded in 2018. The company is focused on developing the next generation gene editing technology that holds promising potential across various applications, particularly in creating new therapeutic options for patients with rare diseases.
In their most recent funding round on 28 September 2023, Pencil Biosciences secured a £5.60M Seed Round investment from a consortium of notable investors. The investment was led by Octopus Ventures, Martlet Capital, UK Innovation & Science Seed Fund, Catapult Venture Managers, Future Planet Capital, Northern Gritstone, o2h Ventures, SyndicateRoom, and Jonathan Milner.
The company's mission to revolutionize gene modulation technology has garnered significant support from key players in the venture capital ecosystem, reflecting confidence in Pencil Biosciences' potential to pioneer advancements in the biotechnology and healthcare industries.
No recent news or press coverage available for Pencil Biosciences Limited.